Protagonist Therapeutics, Inc. (PTGX)

82.76 -0.33 (-0.40%) USD  |  NASDAQ  |  Feb 20, 16:00
82.88 +0.12 (+0.14%) After-Hours: 05:47
More

Protagonist Therapeutics Long Term Deferred Tax Liabilities (Quarterly)

Long Term Deferred Tax Liabilities (Quarterly) Chart

View Long Term Deferred Tax Liabilities (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Liabilities (Quarterly) Benchmarks

View Long Term Deferred Tax Liabilities (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. --
Glaukos Corp. Upgrade
Krystal Biotech, Inc. --
ACADIA Pharmaceuticals, Inc. --